This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
zacks-consensus-estimate: Archive
Plus Therapeutics (PSTV) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Plus (PSTV) delivered earnings and revenue surprises of +88.89% and -18.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PSTVNegative Net Change COONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Bolt Biotherapeutics (BOLT) delivered earnings and revenue surprises of +30.31% and +73.46%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BOLTNegative Net Change ELMDNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
IGC Pharma, Inc. (IGC) delivered earnings and revenue surprises of +33.33% and -0.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
IGCPositive Net Change PINCPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Genasys (GNSS) Reports Q3 Loss, Beats Revenue Estimates
by Zacks Equity Research
Genasys (GNSS) delivered earnings and revenue surprises of -27.27% and +1.10%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GNSSPositive Net Change PVHNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
RenovoRx, Inc. (RNXT) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
RenovoRx (RNXT) delivered earnings and revenue surprises of 0.00% and +22.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
RNXTPositive Net Change HQYNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Evolv Technologies Holdings, Inc. (EVLV) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Evolv Technologies (EVLV) delivered earnings and revenue surprises of -177.78% and +11.26%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
EVLVNegative Net Change SAICNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Profound Medical (PROF) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Profound Medical (PROF) delivered earnings and revenue surprises of -20.93% and -25.05%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PROFPositive Net Change MODVPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
P3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
P3 Health Partners (PIII) delivered earnings and revenue surprises of -89.36% and -2.03%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PIIINegative Net Change PHRNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Applied Materials (AMAT) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Applied Materials (AMAT) delivered earnings and revenue surprises of +5.98% and +1.42%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
AMATNegative Net Change AMBANegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Co-Diagnostics, Inc. (CODX) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
CoDiagnostics (CODX) delivered earnings and revenue surprises of +8.00% and -45.67%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CODXPositive Net Change PACSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Dare Bioscience, Inc. (DARE) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Dare Bioscience (DARE) delivered earnings and revenue surprises of +18.18% and -103.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DARENegative Net Change AUNAPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
MacroGenics (MGNX) delivered earnings and revenue surprises of +3.39% and +4.73%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MGNXNegative Net Change AYRWFNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
TOMI Environmental Solutions, Inc. (TOMZ) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
TOMI Environmental Solutions (TOMZ) delivered earnings and revenue surprises of -100.00% and -41.75%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TOMZNegative Net Change BBCPNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Surging Earnings Estimates Signal Upside for Village Farms (VFF) Stock
by Zacks Equity Research
Village Farms (VFF) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
VFFPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why CorMedix (CRMD) Might be Well Poised for a Surge
by Zacks Equity Research
CorMedix (CRMD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
CRMDPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Surging Earnings Estimates Signal Upside for First Community (FCCO) Stock
by Zacks Equity Research
First Community (FCCO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
FCCONegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Will Zebra (ZBRA) Gain on Rising Earnings Estimates?
by Zacks Equity Research
Zebra Technologies (ZBRA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
ZBRANegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Hecla Mining (HL): Time to Buy?
by Zacks Equity Research
Hecla Mining (HL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
HLNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Earnings Estimates Moving Higher for Ralph Lauren (RL): Time to Buy?
by Zacks Equity Research
Ralph Lauren (RL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
RLNegative Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Will Toronto-Dominion (TD) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Toronto-Dominion (TD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
TDPositive Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Ferrari (RACE) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Ferrari (RACE) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
RACEPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Denison Mine (DNN) Rating Upgrade to Buy
by Zacks Equity Research
Denison Mine (DNN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
DNNPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes Kamada (KMDA) a New Buy Stock
by Zacks Equity Research
Kamada (KMDA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
KMDANegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
First Savings Financial (FSFG) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
First Savings Financial (FSFG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
FSFGNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Ardmore Shipping (ASC) Rating Upgrade to Strong Buy
by Zacks Equity Research
Ardmore Shipping (ASC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
ASCNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank